Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02098187 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetics of MP-3180 and Use of Noninvasive Fluorescence Detection Device in Healthy Volunteers
A Phase 1 study of Acute Kidney Injury and Glomerular Filtration Rate, sponsored by MediBeacon.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT02098187 is a Phase 1 study of Acute Kidney Injury and Glomerular Filtration Rate that has completed, run by MediBeacon. The registered enrollment target is 16 participants, below the 2,331-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02098187, a Phase 1 study of Acute Kidney Injury and Glomerular Filtration Rate, has completed, sponsored by MediBeacon.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this early feasibility study was to investigate the pharmacokinetics of MP-3180 administered in rising doses and to evaluate the use of the Optical Renal Function Monitor (ORFM), an investigational noninvasive fluorescence detection device.
Conditions Studied
Interventions
- DRUG Below target dose MP-3180
- DRUG At target dose MP-3180
- DRUG 2 times above target dose MP-3180
- DRUG 4 times above target dose MP-3180
- DEVICE ORFM prototype
Study Locations (1)
Maryland
- University of Maryland - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2014-03 |
| Est. Completion | 2014-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02098187
The ClinicalTrials.gov registry entry for NCT02098187 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,331-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (99% lower). The listed sponsor is MediBeacon, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Acute Kidney Injury appearing as the primary indexed condition, and to 5 interventions - of which Below target dose MP-3180 is the first listed.
NCT02098187 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT02098187 about?
NCT02098187 is a clinical study titled "Pharmacokinetics of MP-3180 and Use of Noninvasive Fluorescence Detection Device in Healthy Volunteers". The purpose of this early feasibility study was to investigate the pharmacokinetics of MP-3180 administered in rising doses and to evaluate the use of the Optical Renal Function Monitor (ORFM), an investigational noninvasive fluorescence detection device.
What is the current status of trial NCT02098187?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2014-03. Estimated completion is 2014-03.
What conditions does trial NCT02098187 study?
This clinical trial studies the following conditions: Acute Kidney Injury, Glomerular Filtration Rate.
What interventions are being tested in trial NCT02098187?
The interventions under investigation include: Below target dose MP-3180 (DRUG), At target dose MP-3180 (DRUG), 2 times above target dose MP-3180 (DRUG), 4 times above target dose MP-3180 (DRUG), ORFM prototype (DEVICE).
Who is sponsoring clinical trial NCT02098187?
This trial is sponsored by MediBeacon, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02098187 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Kidney Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage
RECRUITING · Phase 1
-
Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury
RECRUITING · Phase 1
-
A Study of the PK Interaction of CXA-10 With Pravastatin and Vytorin® in Healthy Males
COMPLETED · Phase 1
-
Ibuprofen and Biomarkers of Acute Kidney Injury After Running in the Heat
COMPLETED · Phase 1
-
Ultra-Low Contrast Angiography in AKI
RECRUITING · Phase 3
-
Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.